Flavia G. Machado
About Flavia G. Machado
Flavia G. Machado is a Study Director III at Inotiv, where she has worked since 2023. She holds a Ph.D. in Renal Pathophysiology from the University of São Paulo and has extensive experience in research roles across various institutions.
Work at Inotiv
Flavia G. Machado currently serves as Study Director III at Inotiv, a position she has held since 2023. Her role involves overseeing and directing studies within the organization, contributing to the company's research initiatives. Prior to her current position, she worked as Scientist I at Inotiv from 2022 to 2023. Both roles are based on-site in the United States.
Education and Expertise
Flavia G. Machado has an extensive academic background in the field of biology and renal pathophysiology. She earned her Bachelor’s degree in General Biology from Universidade Presbiteriana Mackenzie from 2001 to 2004. She then pursued a Master of Science (M.S.) in Renal Pathophysiology at USP - Universidade de São Paulo from 2005 to 2008, followed by a Doctor of Philosophy (Ph.D.) in the same field from 2008 to 2012.
Background
Flavia G. Machado has a diverse professional background in scientific research. She began her career as a Laboratory Technician at Hospital das Clínicas da Faculdade de Medicina FMUSP in São Paulo, Brazil, from 2010 to 2013. She then transitioned to various research roles, including Postdoctoral Research Fellow at Harvard Medical School from 2013 to 2015 and Postdoctoral Research Associate at Washington University in St. Louis from 2015 to 2017. She also worked as a Research Scientist at Mediomics, LLC from 2018 to 2019 and as Associate Scientist II at Plato BioPharma, Inc. from 2019 to 2022.
Professional Experience
Flavia G. Machado has accumulated significant experience in the life sciences sector. Her roles have included positions in research and development, where she contributed to various scientific studies and projects. Her experience spans over a decade, with positions at notable institutions and companies, reflecting her commitment to advancing research in renal pathophysiology and related fields.